The Wegovy FlexTouch pen is a injectable weight loss medication in the UK containing semaglutide, designed to curb appetite and reduce cravings. Buy Wegovy for a clinically proven medication to aid weight loss alongside healthy lifestyle choices and exercise.
*Buy your first 0.25mg Wegovy FlexTouch Pen at the starting price of £69, with subsequent 0.25mg orders increasing to £119 thereafter.
Lose up to 20.7% with our Wegovy weight loss service
Supported by UK-based clinical expertise and monthly check-ins
No hidden fees (pay-as-you-go)
Wegovy pen prices in the UK start from just £69 for the initial starting dose. This package includes a 4-week supply of Wegovy with free temperature-controlled delivery. If you’re looking to buy Wegovy from Phlo Clinic, we also offer a price match scheme on GLP-1 medication to help keep your costs down whilst still getting access to our treatments and clinical support.
*Get your first 0.25mg Wegovy FlexTouch Pen at the starting price of £69, with subsequent 0.25mg orders increasing to £119 thereafter.
*Discount codes will be auto-applied at checkout to reflect our 2 month bundle prices at these rates.
When you buy Wegovy from Phlo Clinic, you get more than just the prescription. Here’s everything included to support your weight loss journey:
FREE Royal Mail Tracked 24 delivery (temperature-controlled)
Complimentary weight loss kit
Supported by UK-based clinical expertise and monthly check-ins
Monthly check-ins with our clinical team
Dedicated patient care team, 7 days a week
Advice emails and tailored weight loss maintenance support
Dietitian Nutrition Guide
Self-paced 16-week nutrition & behaviour change programme
Beginner’s Guide to GLP-1s (online course)
Access to our Weight Loss Advice Hub
Phlo Nourish is our exclusive weight loss support programme. FREE for Phlo Clinic patients.
16 self-paced Dietitian-led videos
7-day weight loss meal plan
Healthy snack guide
Basic shopping list
Wegovy can help you to lose weight in a healthy, sustainable way. While it shouldn’t be used as “quick fix” it can help to accelerate weight loss that will help to improve your overall metabolic and cardiovascular health and reduce the chance of longer-term health complications.
You are aged between 18 and 85
You have a BMI above 30 or have a BMI above 27 and a weight-related accompanying condition
(e.g. high blood pressure or cholesterol amongst others)
If you’re already on GLP-1 medication and switch to Phlo Clinic, we require a BMI of above 23 with supporting evidence
Supply photographic evidence to verify your consultation.
Meet all other clinical criteria subject to your medical history and GP records.
During the consultation stage we’ll ask you for more specific information to ensure Wegovy is the right option for you.
The Wegovy pen is clinically proven to help weight loss by reducing hunger cravings and curbing appetite. Wegovy should be taken alongside healthy lifestyle choices and exercises for it to be most effective
It’s important to understand what Wegovy is and to take it as directed. Make sure you read our treatment summary below and refer to our Wegovy FAQs alongside the Patient Information Leaflet that comes with your supply.
Semaglutide
FlexTouch Pen (injectable)
Wegovy is started at a low dose and increased gradually every four weeks. This titration approach allows your body to adjust to the medication and significantly reduces the risk and severity of side effects, particularly nausea.
You should never increase your dose faster than the schedule below. If you experience side effects that are difficult to manage, you can stay at your current dose for longer before moving up. Speak to our Phlo Clinic Patient Care Team for guidance.
| Period | Dose | Notes |
|---|---|---|
| Weeks 1-4 |
0.25mg
once weekly |
Starting dose |
| Weeks 5-8 |
0.5mg
once weekly |
First step-up |
| Weeks 9-12 |
1.0mg
once weekly |
|
| Weeks 13-16 |
1.7mg
once weekly |
|
| Weeks 17-20 |
2.4mg
once weekly |
Standard maintenance dose |
| Weeks 21+ |
7.2mg
once weekly |
Higher maintenance dose (optional) |
The 7.2mg dose is prescribed as four single-use pens, to be taken weekly. It is suitable for patients who are stable on 2.4mg with minimal side effects and wish to lose additional weight or have reached a plateau. Read more in our guide to the new Wegovy 7.2mg dose.
Clinical studies have shown that combined with a healthy lifestyle and regular exercise, you can lose up to 5% of your bodyweight in the first 3 months. That increases to up to 20.7%* of your bodyweight within 18 months if you maintain treatment long term.
*This calculator is only an example for illustrative purposes and the results are not guaranteed. Every weight loss experience is unique. This example is based on a study of 1,407 participants on 7.2mg Wegovy showing weight loss of up to 20.7% over a 72-week period
Clinical evidence is robust. In the landmark STEP trials, patients taking Wegovy 2.4mg alongside lifestyle changes lost an average of 14.9% of their starting body weight over 68 weeks.
With the newer 7.2mg dose, the STEP UP trial found average weight loss of 20.7% over 72 weeks.
In practical terms, someone starting at 100kg could expect to lose around 20kg on average over 18 months of treatment. Individual results vary and are best achieved alongside healthy lifestyle changes.
It works for weight loss by binding to the GLP-1 receptor, mimicking the action of GLP-1 in the body. This helps to regulate feelings of fullness in the brain and slows gastric emptying and digestion in the stomach.
Both Mounjaro and Wegovy are clinically proven GLP-1 weight loss injections, and switching between them is more common than many people realise. There are several legitimate reasons to make the move.
Common reasons people switch
from Mounjaro to Wegovy:
Cost: Wegovy can be more cost effective compared to Mounjaro, making it a more affordable option for long-term treatment
Side effects: Some patients find tirzepatide (Mounjaro) causes more pronounced gastrointestinal side effects and tolerate semaglutide (Wegovy) better
Cardiovascular health: Wegovy has a specific MHRA approval for reducing the risk of heart attack and stroke in adults with established heart disease, which may make it the clinically preferred choice for some patients
Personal preference: The FlexTouch pen format suits some patients better than the KwikPen
Both medications work by mimicking GLP-1, a gut hormone that reduces appetite and slows gastric emptying. Mounjaro additionally mimics GIP (a second hormone), which is thought to enhance appetite suppression. Switching from Mounjaro to Wegovy does not mean starting from scratch; our clinical team will recommend an equivalent Wegovy dose based on where you are in your Mounjaro treatment.
Switching is straightforward. You do not need to have been a Phlo Clinic patient previously.
Complete our short online consultation telling us your current Mounjaro dose and treatment history
Our prescribing pharmacists review your case and confirm the appropriate starting Wegovy dose
Your first Wegovy pen is dispatched with free temperature-controlled delivery
Ongoing monthly check-ins and 7-day patient care team access ensure your transition stays on track
For a detailed guide to what the transition involves, read our switching from Mounjaro to Wegovy guide.
You will not need to restart at the lowest 0.25mg dose. Your Wegovy starting dose is matched to your current Mounjaro dose, though your exact dose will be confirmed during your clinical consultation.
In this video, Phlo Clinic’s Head of Patient Services tells you all you need to know
Fully GPhC certified
Our expert prescribing pharmacists are specially trained to review, consult and provide medications online. Your healthcare journey is in safe hands.
Our services are delivered by a team of dedicated pharmacists, prescribers and clinicians.
Share in the weight loss experiences of Phlo Clinic patients* just like you and why they trust us to help achieve their goals. Let’s do this together.
Like all medications, Wegovy can cause side effects. Most are mild to moderate, tend to occur when first starting treatment or after a dose increase, and improve as your body adjusts. The gradual dose escalation schedule is specifically designed to minimise their impact.
These are the most frequently reported and almost always settle within the first few weeks:
Nausea or vomiting
Diarrhoea or constipation
Stomach pain or discomfort
Headache
Fatigue or feeling weak
Managing nausea: eat smaller meals more frequently, avoid rich or fatty foods, stay well hydrated, and avoid lying down immediately after eating. For more tips, read our nausea and vomiting on Wegovy guide.
Dizziness or lightheadedness
Indigestion, heartburn, or acid reflux
Bloating, burping, or flatulence
Inflamed stomach (gastritis)
Gallstones
Hair loss (usually temporary, related to rapid weight loss)
Injection site reactions: redness, swelling, or bruising
Changes in taste or skin sensation
Low blood sugar (hypoglycaemia) in patients also taking insulin or sulfonylureas
For guidance on managing digestive side effects, see our constipation and diarrhoea guide.
Fast heartbeat
Kidney or bladder stones
Low blood sugar in people without diabetes
Elevated pancreatic enzymes (detected in blood tests)
Choosing Phlo Clinic means you’re in control of your healthcare. No more dreaded busy tone or long waiting lists – we’ve got you covered.
To make sure you can safely take your preferred treatment, complete our questionnaire which takes approx 3 mins.
Our prescribing pharmacists review and individually assess your treatment suitability using their extensive knowledge and clinical experience.
Once approved and dispensed, we’ll securely deliver your treatment anywhere you need using our free Royal Mail Tracked 24 option.
Start your weight loss journey with Phlo Clinic
